Florascience Inc.

United States of America

Back to Profile

1-8 of 8 for Florascience Inc. Sort by
Query
Aggregations
Jurisdiction
        United States 4
        World 3
        Canada 1
Date
2025 5
2024 3
IPC Class
A61K 31/00 - Medicinal preparations containing organic active ingredients 4
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia 3
C07D 311/80 - DibenzopyransHydrogenated dibenzopyrans 3
A61P 25/20 - HypnoticsSedatives 2
B01J 27/06 - HalogensCompounds thereof 2
See more
Status
Pending 3
Registered / In Force 5
Found results for  patents

1.

METHODS OF PREPARING CANNABINOIDS OR DERIVATIVES THEREOF

      
Application Number US2024010195
Publication Number 2025/147239
Status In Force
Filing Date 2024-01-03
Publication Date 2025-07-10
Owner FLORASCIENCE INC. (USA)
Inventor
  • Jensen, Robert Paul
  • Hartung, Vaughn

Abstract

Provided are methods of preparing cannabinol from cannabidiol and/ or tetrahydrocannabinol and for preparing cannabinol acetate. The methods comprise using catalytic molecular halogen in the presence of an oxidant.

IPC Classes  ?

  • C07D 311/80 - DibenzopyransHydrogenated dibenzopyrans

2.

Methods of preparing cannabinoids or derivatives thereof

      
Application Number 18403509
Grant Number 12371412
Status In Force
Filing Date 2024-01-03
First Publication Date 2025-07-03
Grant Date 2025-07-29
Owner FloraScience Inc. (USA)
Inventor
  • Jensen, Robert Paul
  • Hartung, Vaughn

Abstract

Provided are methods of preparing cannabinoids and cannabinoid derivatives and compositions containing the cannabinoids and derivatives.

IPC Classes  ?

3.

Methods of preparing cannabinoids or derivatives thereof

      
Application Number 18739493
Grant Number 12281091
Status In Force
Filing Date 2024-06-11
First Publication Date 2025-04-22
Grant Date 2025-04-22
Owner FloraScience Inc. (USA)
Inventor
  • Jensen, Robert Paul
  • Hartung, Vaughn

Abstract

Provided are methods of preparing cannabinoids and cannabinoid derivatives and compositions containing the cannabinoids and derivatives.

IPC Classes  ?

4.

COMPOSITIONS AND METHODS FOR REDUCING SLEEP DISTURBANCES AND TREATING SLEEP DISORDERS

      
Application Number 18444077
Status Pending
Filing Date 2024-02-16
First Publication Date 2025-01-09
Owner FloraScience Inc. (USA)
Inventor
  • Jensen, Robert Paul
  • Hartung, Vaughn
  • Lindquist, Alleh

Abstract

Provided are compositions containing cannabinol, or a pharmaceutically acceptable salt thereof, and methods of reducing sleep disturbances in a subject, comprising administering the cannabinol composition to the subject. Also provided are methods of treating sleep disorders in a subject, comprising administering the cannabinol composition to the subject.

IPC Classes  ?

  • A61K 31/00 - Medicinal preparations containing organic active ingredients
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61P 25/20 - HypnoticsSedatives

5.

COMPOSITIONS AND METHODS COMPRISING CANNABINOL FOR REDUCING SLEEP DISTURBANCES AND TREATING SLEEP DISORDERS

      
Application Number US2024016145
Publication Number 2025/006008
Status In Force
Filing Date 2024-02-16
Publication Date 2025-01-02
Owner FLORASCIENCE INC. (USA)
Inventor
  • Jensen, Robert Paul
  • Hartung, Vaughn
  • Lindquist, Alleh

Abstract

Provided are compositions containing cannabinol, or a pharmaceutically acceptable salt thereof, and methods of reducing sleep disturbances in a subject, comprising administering the cannabinol composition to the subject. Also provided are methods of treating sleep disorders in a subject, comprising administering the cannabinol composition to the subject.

IPC Classes  ?

  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/05 - Phenols
  • A61P 25/20 - HypnoticsSedatives

6.

METHODS OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS

      
Application Number 18403664
Status Pending
Filing Date 2024-01-03
First Publication Date 2024-08-08
Owner
  • FloraScience Inc. (USA)
  • The Salk Institute for Biological Studies (USA)
Inventor
  • Jensen, Robert Paul
  • Maher, Pamela
  • Liang, Zhibin

Abstract

Provided are methods of treating a neurodegenerative disease or condition in a subject in need thereof including administering a cannabinoid to the subject.

IPC Classes  ?

  • A61K 31/00 - Medicinal preparations containing organic active ingredients
  • A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

7.

METHODS OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS

      
Document Number 03279118
Status Pending
Filing Date 2024-01-03
Open to Public Date 2024-07-11
Owner FLORASCIENCE INC. (USA)
Inventor
  • Jensen, Robert Paul
  • Maher, Pamela
  • Liang, Zhibin

IPC Classes  ?

  • A61K 31/00 - Medicinal preparations containing organic active ingredients
  • A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

8.

CANNABINOIDS FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE OR CONDITION

      
Application Number US2024010214
Publication Number 2024/148117
Status In Force
Filing Date 2024-01-03
Publication Date 2024-07-11
Owner FLORASCIENCE INC. (USA)
Inventor
  • Jensen, Robert Paul
  • Maher, Pamela
  • Liang, Zhibin

Abstract

Provided are methods of treating a neurodegenerative disease or condition in a subject in need thereof including administering a cannabinoid to the subject.

IPC Classes  ?

  • A61K 31/00 - Medicinal preparations containing organic active ingredients
  • A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia